Comparative efficacy of prophylactic monoclonal (OKT3) and polyclonal antibodies (ATG) in immunologic high-risk renal transplant recipients

Transplant Proc. 1996 Oct;28(5):2808-9.

Authors

F Fukuuchi¹, N Lefrançois, F Chapuis, L Gebuhrer, S Bosshard, J M Dubernard, J L Touraine

Affiliation

¹ Unit of transplantation, Hôpital Edouard Herriot, Lyon, France.

PMID: 8908070

No abstract available

Publication types

Comparative Study

MeSH terms

Antilymphocyte Serum / therapeutic use*
Azathioprine / therapeutic use
Chi-Square Distribution
Cyclosporine / therapeutic use
Cytomegalovirus Infections / epidemiology
Graft Survival*
Humans
Immunization
Immunosuppression Therapy / methods*
Immunosuppressive Agents / therapeutic use
Kidney Neoplasms / immunology*
Kidney Neoplasms / mortality
Methylprednisolone / therapeutic use
Muromonab-CD3 / therapeutic use*
Postoperative Complications
Prednisolone / therapeutic use
Retrospective Studies
Survival Rate
Time Factors

Substances

Antilymphocyte Serum
Immunosuppressive Agents
Muromonab-CD3
Cyclosporine
Prednisolone
Azathioprine
Methylprednisolone